Skip to main content

ADVERTISEMENT

Jean-Pierre Lindenmayer, MD

Treatment-resistant schizophrenia (TRS) occurs in up to 30% of patients with schizophrenia and is defined as the persistence of positive symptoms despite ≥2 trials of antipsychotic (AP) m...
03/01/2019
11/22/2019